While evidence suggests pathological proteins linked to the onset and progression of neurodegenerative disorders are capable of spreading from cell-to-cell within the brains of affected individuals, new research shows no evidence to support concerns that these abnormal disease proteins are “infectious” or transmitted from animals to humans or from one person to another.
New research supports the idea that a malfunction of the TDP-43 protein plays a decisive role in the development of ALS and FTD.
Performing post-mortem staging of the brains and spinal cord tissue of patients with ALS, researchers discover the neurodegenerative disease could progress from one start point in the CNS to other regions of the brain and spinal cord.
Researchers discover a new way of reducing disease toxicity in ALS which slows the dysfunction of neurons.
Researchers have discovered how a molecular scaffold, that allows key parts of cells to interact, comes apart in some neurodegenerative diseases.
Researchers report retinal degeneration could be one of the earliest signs of FTD in people who have a genetic risk for the disorder.
Researchers believe mouse could provide a new platform for testing treatments for several neurodegenerative diseases.
Researchers have developed a new model to study neurodegenerative diseases which affect motor neurons, such as ALS.
A new study reports people may lose awareness of their memory loss almost three years prior to Alzheimer's disease setting in.